Literature DB >> 15375299

Risk factors for vascular dementia and Alzheimer disease.

Philip B Gorelick1.   

Abstract

Alzheimer disease and vascular cognitive impairment are important causes of cognitive decline in the elderly. It has now been shown that vascular risk factors have measurable negative effects on the brain and are associated with cognitive impairment. We review vascular factors that might be responsible to cognitive decline in Alzheimer disease and vascular cognitive impairment and the corresponding interventions that might prevent cognitive impairment as we age.

Entities:  

Mesh:

Year:  2004        PMID: 15375299     DOI: 10.1161/01.STR.0000143318.70292.47

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  107 in total

1.  Vascular cognitive impairment.

Authors:  Laura Pedelty; David L Nyenhuis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-05

2.  Smoking cessation and Alzheimer's disease: facts, fallacies and promise.

Authors:  Janine K Cataldo; Stanton A Glantz
Journal:  Expert Rev Neurother       Date:  2010-05       Impact factor: 4.618

Review 3.  Vascular aspects of cognitive impairment and dementia.

Authors:  Maximilian Wiesmann; Amanda J Kiliaan; Jurgen A H R Claassen
Journal:  J Cereb Blood Flow Metab       Date:  2013-09-11       Impact factor: 6.200

4.  CEREBRAL AMYLOID ANGIOPATHY AND ALZHEIMER'S DISEASE.

Authors:  Jorge Ghiso; Yasushi Tomidokoro; Tamas Revesz; Blas Frangione; Agueda Rostagno
Journal:  Hirosaki Igaku       Date:  2010-07-08

5.  Determinants of vascular dementia in the Cardiovascular Health Cognition Study.

Authors:  L H Kuller; O L Lopez; W J Jagust; J T Becker; S T DeKosky; C Lyketsos; C Kawas; J C S Breitner; A Fitzpatrick; C Dulberg
Journal:  Neurology       Date:  2005-05-10       Impact factor: 9.910

6.  Changing the course of Alzheimer's disease: anti-amyloid disease-modifying treatments on the horizon.

Authors:  Daniel D Christensen
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

7.  Perlecan domain V inhibits amyloid-β induced brain endothelial cell toxicity and restores angiogenic function.

Authors:  Christi Parham; Lisa Auckland; Jessica Rachwal; Douglas Clarke; Gregory Bix
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

8.  Lifestyle and Neurocognition in Older Adults With Cardiovascular Risk Factors and Cognitive Impairment.

Authors:  James A Blumenthal; Patrick J Smith; Stephanie Mabe; Alan Hinderliter; Kathleen Welsh-Bohmer; Jeffrey N Browndyke; Pao-Hwa Lin; William Kraus; P Murali Doraiswamy; James Burke; Andrew Sherwood
Journal:  Psychosom Med       Date:  2017 Jul/Aug       Impact factor: 4.312

Review 9.  Omega-3 fatty acids and cognitive function in women.

Authors:  Jennifer G Robinson; Nkechinyere Ijioma; William Harris
Journal:  Womens Health (Lond)       Date:  2010-01

10.  Increased risk of dementia among chronic osteomyelitis patients.

Authors:  C-H Tseng; W-S Huang; C-H Muo; C-H Kao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-08-07       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.